Impact of Comorbidity on Overall Survival in Patients Surgically Treated for Renal Cell Carcinoma

Urology

Volumn 72, Issue 2, 2008, Pages 359-363

  Berger, David A ^a   Megwalu, Ifeanyichukwu I ^a   Vlahiotis, Anna ^a   Radwan, Mohamed H ^a   Serrano, Maria F ^a   Humphrey, Peter A ^a,b   Piccirillo, Jay F ^a,b   Kibel, Adam S ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMORBIDITY; CONFIDENCE INTERVAL; ETHNICITY; FEMALE; FOLLOW UP; HAZARD RATIO; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PARTIAL NEPHRECTOMY; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; TUMOR VOLUME; UNIVARIATE ANALYSIS;

CARCINOMA, RENAL CELL; COMORBIDITY; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEPHRECTOMY; PROGNOSIS; SURVIVAL RATE;

EID: 48449088379     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.02.061     Document Type: Article

References (22)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
2. Hollingsworth J.M., Miller D.C., Daignault S., et al. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 98 (2006) 1331-1334
3. Frank I., Blute M.L., Cheville J.C., et al. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 170 (2003) 2217-2220
4. Sorbellini M., Kattan M.W., Snyder M.E., et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol 173 (2005) 48-51
5. Thrasher J.B., and Paulson D.F. Prognostic factors in renal cancer. Urol Clin North Am 20 (1993) 247-262
6. Weiss R.H., Borowsky A.D., Seligson D., et al. p21 is a prognostic marker for renal cell carcinoma: implications for novel therapeutic approaches. J Urol 177 (2007) 63-69
7. Kramer B.A., Gao X., Davis M., et al. Prognostic significance of ploidy, MIB-1 proliferation marker, and p53 in renal cell carcinoma. J Am Coll Surg 201 (2005) 565-570
8. Thompson R.H., Kuntz S.M., Leibovich B.C., et al. Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. Cancer Res 66 (2006) 3381-3385
9. Kim H.L., Seligson D., Liu X., et al. Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma. J Urol 173 (2005) 1496-1501
10. Feinstein A.R. The pre-therapeutic classification of co-morbidity in chronic disease. J Chron Dis 23 (1970) 455-469
11. Piccirillo J.F., Tierney R.M., Costas I., et al. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 291 (2004) 2441-2447
12. Tammemagi C.M., Neslund-Dudas C., Simoff M., et al. In lung cancer patients, age, race-ethnicity, gender and smoking predict adverse comorbidity, which in turn predicts treatment and survival. J Clin Epidemiol 57 (2004) 597-609
13. Post P.N., Hansen B.E., Kil P.J., et al. The independent prognostic value of comorbidity among men aged <75 years with localized prostate cancer: a population-based study. BJU Int 87 (2001) 821-826
14. Yancik R., Wesley M.N., Ries L.A., et al. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer 82 (1998) 2123-2134
15. Read W.L., Tierney R.M., Page N.C., et al. Differential prognostic impact of comorbidity. J Clin Oncol 22 (2004) 3099-3103
16. Berndt S.I., Carter H.B., Schoenberg M.P., et al. Disparities in treatment and outcome for renal cell cancer among older black and white patients. J Clin Oncol 25 (2007) 3589-3595
17. Zisman A., Pantuck A.J., Dorey F., et al. Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol 19 (2001) 1649-1657
18. Zisman A., Pantuck A.J., Dorey F., et al. Mathematical model to predict individual survival for patients with renal cell carcinoma. J Clin Oncol 20 (2002) 1368-1374
19. Han K.R., Bleumer I., Pantuck A.J., et al. Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population. J Urol 170 (2003) 2221-2224
20. Gettman M.T., Boelter C.W., Cheville J.C., et al. Charlson co-morbidity index as a predictor of outcome after surgery for renal cell carcinoma with renal vein, vena cava or right atrium extension. J Urol 169 (2003) 1282-1286
21. Patard J.J., Leray E., Rioux-Leclercq N., et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 23 (2005) 2763-2771
22. Parsons J.K., Schoenberg M.S., and Carter H.B. Incidental renal tumors: Casting doubt on the efficacy of early intervention. Urology 57 (2001) 1013-1015